Healthcaps India Share Price

About HEALTHCAPS INDIA LIMITED Unlisted Shares

HEALTHCAPS INDIA LIMITED was incorporated on 06 December 1982. It is classified as a Non-govt company and is registered at Registrar of Companies, Chandigarh. Healthcaps India Limited is a WHO-GMP Certified Company and is in the production of Empty Hard Gelatin Capsule Shells (I.P. / B.P.). Healthcaps India Limited products are widely used in the encapsulation of drugs, vitamins, antibiotics, etc, whether in powder or in pellet form by major pharmaceutical companies in India and abroad. Healthcaps India Limited also manufactures BSE/TSE-free EHG Capsules using EDQM-approved gelatin. With the objective of creating an eco-friendly environment, with stringent quality control checks in place, the company chose the open spaces in Fatehpur, Punjab, 60 km from Chandigarh for its manufacturing facility. And to facilitate easy interaction with clients, it has established offices in Chandigarh, New Delhi, and Mumbai. The company's vision is to become a global leader in the manufacture of empty capsules, setting benchmarks in quality and regulatory systems, and creating new market spaces with a focus on innovation.

HEALTHCAPS INDIA INCORPORATION DETAILS

PRINCIPAL BUSINESS ACTIVITIES OF THE COMPANY

HEALTHCAPS INDIA BOARD OF DIRECTORS

Mr. Chiranjiv Singh (Managing Director)

Mrs. Hariti Singh (Whole Time Director)

Mr. I. S. Bindra (Director)

Mr. Gurucharan Singh (Independent Director)

Mr. ArunBhakoo (Independent Director)

PARTICULARS OF HEALTHCAPS INDIA SUBSIDIARY AND ASSOCIATE COMPANIES

HEALTHCAPS INDIA LIMITED does not have any subsidiary or associate company.

SHAREHOLDING PATTERN of HEALTHCAPS INDIA (As of 31-03-2024)

INDUSTRY OUTLOOK

Indian Pharmaceutical market ranks as 3rd largest in the world in terms of volume and the 14th largest in terms of value. Healthcare has become one of the largest sectors of the Indian economy, in terms of both employment and revenue. India is known as the Pharmacy of the world and is the largest provider of generic drugs at a global level. The pharmaceutical industry of India supplies over 50% of the global demand for various vaccines, 40% of the generic demand in the USA, and 25% of all medicines in the United Kingdom. Excellent Research and development, low cost of labor, availability of management and technical personnel, and local equipment availability have helped India to manufacture pharma products at a very low cost.